ZIRDAWNY

Serial Number 99115707
688

Registration Progress

Application Filed
Apr 1, 2025
Under Examination
Nov 25, 2025
Approved for Publication
Sep 30, 2025
Published for Opposition
Sep 30, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 25, 2026 145 days

Trademark Image

ZIRDAWNY

Basic Information

Serial Number
99115707
Filing Date
April 1, 2025
Published for Opposition
September 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Nov 25, 2025
Application
Pending
Classes
005

Rights Holder

Ionis Pharmaceuticals, Inc.

03
Address
2850 Gazelle Court
Carlsbad, CA 92010

Ownership History

Ionis Pharmaceuticals, Inc.

Original Applicant
03
Carlsbad, CA

Ionis Pharmaceuticals, Inc.

Owner at Publication
03
Carlsbad, CA

Legal Representation

Attorney
Brian Focarino

USPTO Deadlines

Next Deadline
145 days remaining
NOA E-Mailed - SOU Required
Due Date
May 25, 2026
Extension Available
Until November 25, 2026

Application History

14 events
Date Code Type Description Documents
Nov 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 30, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 30, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 24, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 2, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 2, 2025 ALIE A ASSIGNED TO LIE Loading...
Sep 2, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 2, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 2, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 29, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 1, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 1, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of edema, namely, hereditary angioedema; pharmaceutical products and preparations in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders

Classification

International Classes
005